JNJ - Macro View 🌐Hello TradingView Family / Fellow Traders. This is Richard, also known as theSignalyst.
📈 JNJ has exhibited an overall bullish trend, trading within the ascending wedge pattern outlined in blue. It is presently nearing the lower boundary/blue trendline.
At present, JNJ is undergoing a correction p
JOHNSON & JOHNSON
154.6000GBPD
+1.7000+1.11%
Last update at May 30, 18:14 GMT
GBP
No trades
Key facts today
European regulators have reclassified JNJ-1900 from a medical device to a drug, aligning its status with the US and other markets, aiding Johnson & Johnson's regulatory efforts.
About Johnson & Johnson
Sector
Industry
CEO
Joaquin Duato
Website
Headquarters
New Brunswick
Founded
1887
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
10%
21%
32%
43%
54%
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
5.00 B
10.00 B
15.00 B
20.00 B
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
0.00
4.50 B
9.00 B
13.50 B
18.00 B
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
0.00
4.50 B
9.00 B
13.50 B
18.00 B
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
11.00 B
22.00 B
33.00 B
44.00 B
Debt
Free cash flow
Cash & equivalents
No news here
Looks like there's nothing to report right now
JNJ - Where are you heading Johnson?Good Morning,
Hope all is well. Chart explains it all. Still in a downtrend JNJ is fighting. Looks like we have some momentum forming, lets see how strong it is. Failure to break EMA/Resistance would be bearish, otherwise a break would be bullish.
Enjoy!
NLong

JNJ - 2 scenariosHi traders,
JNJ is currently consolidating inside a symmetrical triangle.
We can expect two scenarios:
Bullish scenario:
Open a long position if the price breaks the downsloping resistance line.
SL: below $153.50
Potential TP: $164
Bearish scenario:
Open a short position if the price breaks down a
JOHNSON AND JOHNSON: Re-accumulation is targeting $175.JNJ is neutral on its 1D technical outlook (RSI = 49.991, MACD = -1.040, ADX = 18.184) as it's only trading around its 1W MA50 but having made an impressive rebound 4 weeks ago inside the Demand Zone. This is the 4th time this Demand Zone provided a rally and the last one even crossed over the 3 yea
NLong

Long and LongerMomentum demonstrated in the recent chart is significant enough to break out of anything sideways.
Potential for an increase to a $200 JNJ is not unreasonable.
NLong

Buy JNJ for Stable Gains Amid Earnings Optimism Next Week
- Key Insights: Johnson & Johnson demonstrated robust earnings performance with
an EPS of $2.77, surpassing consensus estimates and reinforcing its
defensive stock status. Its diverse portfolio and consistent ability to
execute in volatile markets make it a strong candidate for growth-oriente
NLong

Johnson & Johnson Wave Analysis – 18 April 2025
- Johnson & Johnson rising inside weekly price range
- Likely to test resistance level 165.60
Johnson & Johnson continues to rise in the primary upward impulse wave 3, which started earlier from the major support level 145.00 (lower border of the weekly sideways price range from 2023).
The up
NLong

Johnson & Johnson Beats Q1 Estimates, Premarket Not Doing WellJohnson & Johnson (NYSE: NYSE:JNJ ) on Tuesday reported better-than-expected Q1 results and lifted its sales forecast for the full year.
Johnson & Johnson (NYSE: NYSE:JNJ ), together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the h
NLong

See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US478160CS1
JOHNSON&JOHN 20/50Yield to maturity
6.89%
Maturity date
Sep 1, 2050
US478160CT9
JOHNSON&JOHN 20/60Yield to maturity
6.85%
Maturity date
Sep 1, 2060
US478160CR3
JOHNSON&JOHN 20/40Yield to maturity
6.22%
Maturity date
Sep 1, 2040
US478160CM4
JOHNSON & JOHNSON 17/48Yield to maturity
6.17%
Maturity date
Jan 15, 2048
US478160BV5
JOHNSON & JOHNSON 16/46Yield to maturity
6.01%
Maturity date
Mar 1, 2046
JNJJ
JOHNSON & JOHNSON 17/47Yield to maturity
5.96%
Maturity date
Mar 3, 2047
JNJB
JOHNSON & JOHNSON 13/43Yield to maturity
5.48%
Maturity date
Dec 5, 2043
US478160CX0
JOHNSON&JOHN 24/54Yield to maturity
5.45%
Maturity date
Jun 1, 2054
US478160CL6
JOHNSON & JOHNSON 17/38Yield to maturity
5.42%
Maturity date
Jan 15, 2038
US478160CF9
JOHNSON & JOHNSON 17/37Yield to maturity
5.22%
Maturity date
Mar 3, 2037
US478160BA1
JOHNSON & JOHNSON 11/41Yield to maturity
5.20%
Maturity date
May 15, 2041
See all 0R34 bonds
Curated watchlists where 0R34 is featured.